North America Gynecological Devices Market Outlook to 2023

  • ID: 4228984
  • Report
  • Region: America, North America, United States
  • 163 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Bayer AG
  • Boston Scientific Corp
  • Cook Group Inc
  • CooperSurgical Inc
  • Ethicon Inc
  • Hologic Inc
  • MORE
North America Gynecological Devices Market Outlook to 2023

Summary

The author’s new report, "North America Gynecological Devices Market Outlook to 2023", provides key market data on the North America Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Gynecological Devices market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the North America Gynecological Devices market.
- Key players covered include Hologic Inc, CooperSurgical Inc, Ethicon Inc and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bayer AG
  • Boston Scientific Corp
  • Cook Group Inc
  • CooperSurgical Inc
  • Ethicon Inc
  • Hologic Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Gynecological Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Gynecological Devices Market, North America
3.1 Gynecological Devices Market, North America, Revenue ($m), 2009-2023
3.2 Gynecological Devices Market, North America, Revenue ($m), 2009-2016
3.3 Gynecological Devices Market, North America, Revenue ($m), 2016-2023
3.4 Gynecological Devices Market, North America, Volume (Units), 2009-2023
3.5 Gynecological Devices Market, North America, Volume (Units), 2009-2016
3.6 Gynecological Devices Market, North America, Volume (Units), 2016-2023
3.7 Gynecological Devices Market, North America, Company Share by Revenue ($m), 2016
4 Gynecological Devices Market, Canada
4.1 Gynecological Devices Market, Canada, Revenue ($m), by Segment, 2009-2016
4.2 Gynecological Devices Market, Canada, Revenue ($m) by Segment, 2016-2023
4.2.1 Endometrial Ablation Devices Market, Canada, Revenue ($m), by Segment, 2009-2016
4.2.2 Female Sterilization Devices Market, Canada, Revenue ($m), by Segment, 2009-2016
4.2.3 Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), by Segment, 2009-2016
4.2.4 Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), by Segment, 2009-2016
4.2.5 Endometrial Ablation Devices Market, Canada, Revenue ($m) by Segment, 2016-2023
4.2.6 Female Sterilization Devices Market, Canada, Revenue ($m) by Segment, 2016-2023
4.2.7 Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) by Segment, 2016-2023
4.2.8 Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) by Segment, 2016-2023
4.3 Gynecological Devices Market, Canada, Volume (Units) by Segment, 2009-2016
4.4 Gynecological Devices Market, Canada, Volume (Units) by Segment, 2016-2023
4.4.1 Endometrial Ablation Devices Market, Canada, Volume (Units) by Segment, 2009-2016
4.4.2 Female Sterilization Devices Market, Canada, Volume (Units) by Segment, 2009-2016
4.4.3 Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) by Segment, 2009-2016
4.4.4 Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) by Segment, 2009-2016
4.4.5 Endometrial Ablation Devices Market, Canada, Volume (Units) by Segment, 2016-2023
4.4.6 Female Sterilization Devices Market, Canada, Volume (Units) by Segment, 2016-2023
4.4.7 Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) by Segment, 2016-2023
4.4.8 Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) by Segment, 2016-2023
4.5 Gynecological Devices Market, Canada, Average Price ($), 2009-2023
4.6 Gynecological Devices Market, Canada, Distribution Share by Revenue ($m), 2016
4.7 Gynecological Devices Market, Canada, Company Share by Revenue ($m), 2016
5 Gynecological Devices Market, Mexico
5.1 Gynecological Devices Market, Mexico, Revenue ($m), 2009-2016
5.2 Gynecological Devices Market, Mexico, Revenue ($m), 2016-2023
5.2.1 Endometrial Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2009-2016
5.2.2 Female Sterilization Devices Market, Mexico, Revenue ($m), by Segment, 2009-2016
5.2.3 Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), by Segment, 2009-2016
5.2.4 Endometrial Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023
5.2.5 Female Sterilization Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023
5.2.6 Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), by Segment, 2016-2023
5.2.7 Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), by Segment, 2016-2023
5.3 Gynecological Devices Market, Mexico, Volume (Units), 2009-2016
5.4 Gynecological Devices Market, Mexico, Volume (Units), 2016-2023
5.4.1 Endometrial Ablation Devices Market, Mexico, Volume (Units), by Segment, 2009-2016
5.4.2 Female Sterilization Devices Market, Mexico, Volume (Units), by Segment, 2009-2016
5.4.3 Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), by Segment, 2009-2016
5.4.4 Endometrial Ablation Devices Market, Mexico, Volume (Units), by Segment, 2016-2023
5.4.5 Female Sterilization Devices Market, Mexico, Volume (Units), by Segment, 2016-2023
5.4.6 Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), by Segment, 2016-2023
5.4.7 Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), by Segment, 2016-2023
5.5 Gynecological Devices Market, Mexico, Average Price ($), 2009-2023
5.6 Gynecological Devices Market, Mexico, Distribution Share by Revenue ($m), 2016
5.7 Gynecological Devices Market, Mexico, Company Share by Revenue ($m), 2016
6 Gynecological Devices Market, United States
6.1 Gynecological Devices Market, United States, Revenue ($m), 2009-2016
6.2 Gynecological Devices Market, United States, Revenue ($m), 2016-2023
6.2.1 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016
6.2.2 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2009-2016
6.2.3 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016
6.2.4 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2009-2016
6.2.5 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023
6.2.6 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2016-2023
6.2.7 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023
6.2.8 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2016-2023
6.3 Gynecological Devices Market, United States, Volume (Units), 2009-2016
6.4 Gynecological Devices Market, United States, Volume (Units), 2016-2023
6.4.1 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016
6.4.2 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2009-2016
6.4.3 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016
6.4.4 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2009-2016
6.4.5 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023
6.4.6 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2016-2023
6.4.7 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023
6.4.8 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2016-2023
6.5 Gynecological Devices Market, United States, Average Price ($), 2009-2023
6.6 Gynecological Devices Market, United States, Distribution Share by Revenue ($m), 2016
6.7 Gynecological Devices Market, United States, Company Share by Revenue ($m), 2016
7 Overview of Key Companies in North America Gynecological Devices Market
7.1 Bayer AG
7.1.1 Company Overview
7.2 Hologic Inc
7.2.1 Company Overview
7.3 Utah Medical Products, Inc.
7.3.1 Company Overview
7.4 CooperSurgical Inc
7.4.1 Company Overview
7.5 Ethicon Inc
7.5.1 Company Overview
7.6 Boston Scientific Corp
7.6.1 Company Overview
7.7 Merit Medical Systems, Inc.
7.7.1 Company Overview
7.8 Cook Group Inc
7.8.1 Company Overview
8 Gynecological Devices Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members
9.1.2 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer
9.1.3 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer
9.1.4 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer
9.2 Financial Announcements
9.2.1 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year
9.2.2 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million
9.2.3 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 Consulting
10.3 Contact
10.4 Disclaimer

List of Tables
Table 1: Gynecological Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023
Table 2: Gynecological Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016
Table 3: Gynecological Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023
Table 4: Gynecological Devices Market, North America, Volume (Units), 2009-2023
Table 5: Gynecological Devices Market, North America, Volume (Units), Historic, 2009-2016
Table 6: Gynecological Devices Market, North America, Volume (Units), Forecast, 2016-2023
Table 7: Gynecological Devices Market, North America, Company Share by Revenue ($m), USD Constant, 2016
Table 8: Gynecological Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 9: Gynecological Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Table 10: Endometrial Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 11: Female Sterilization Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 12: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 13: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Table 14: Endometrial Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Table 15: Female Sterilization Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Table 16: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Table 17: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Table 18: Gynecological Devices Market, Canada, Volume (Units) , Historic, 2009-2016
Table 19: Gynecological Devices Market, Canada, Volume (Units) , Forecast, 2016-2023
Table 20: Endometrial Ablation Devices Market, Canada, Volume (Units) , Historic, 2009-2016
Table 21: Female Sterilization Devices Market, Canada, Volume (Units) , Historic, 2009-2016
Table 22: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) , Historic, 2009-2016
Table 23: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) , Historic, 2009-2016
Table 24: Endometrial Ablation Devices Market, Canada, Volume (Units) , Forecast, 2016-2023
Table 25: Female Sterilization Devices Market, Canada, Volume (Units) , Forecast, 2016-2023
Table 26: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units) , Forecast, 2016-2023
Table 27: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units) , Forecast, 2016-2023
Table 28: Gynecological Devices Market, Canada, Average Price ($) Historic, 2009-2016
Table 29: Gynecological Devices Market, Canada, Average Price ($), Forecast, 2016-2023
Table 30: Gynecological Devices Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2016
Table 31: Gynecological Devices Market, Canada, Company Share by Revenue ($m), USD Constant, 2016
Table 32: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Table 33: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 34: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Table 35: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Table 36: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Table 37: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 38: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 39: Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 40: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 41: Gynecological Devices Market, Mexico, Volume (Units), Historic, 2009-2016
Table 42: Gynecological Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Table 43: Endometrial Ablation Devices Market, Mexico, Volume (Units), Historic, 2009-2016
Table 44: Female Sterilization Devices Market, Mexico, Volume (Units), Historic, 2009-2016
Table 45: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Historic, 2009-2016
Table 46: Endometrial Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Table 47: Female Sterilization Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Table 48: Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Table 49: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Forecast, 2016-2023
Table 50: Gynecological Devices Market, Mexico, Average Price ($) Historic, 2009-2016
Table 51: Gynecological Devices Market, Mexico, Average Price ($), Forecast, 2016-2023
Table 52: Gynecological Devices Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2016
Table 53: Gynecological Devices Market, Mexico, Company Share by Revenue ($m), USD Constant, 2016
Table 54: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 55: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 56: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 57: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 58: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 59: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 60: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 61: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 62: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 63: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 64: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 65: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 66: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 67: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 68: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 69: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016
Table 70: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 71: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 72: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 73: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023
Table 74: Gynecological Devices Market, United States, Average Price ($) Historic, 2009-2016
Table 75: Gynecological Devices Market, United States, Average Price ($), Forecast, 2016-2023
Table 76: Gynecological Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016
Table 77: Gynecological Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 78: Gynecological Devices Market Pipeline Products
Table 79: Total Number of Primary Research Participants General Surgery Market, by Country

List of Figures
Figure 1: Gynecological Devices Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2009-2023
Figure 2: Gynecological Devices Market, North America, Revenue ($m), Historic, USD Constant, 2009-2016
Figure 3: Gynecological Devices Market, North America, Revenue ($m), Forecast, USD Constant, 2016-2023
Figure 4: Gynecological Devices Market, North America, Volume (Units), 2009-2023
Figure 5: Gynecological Devices Market, North America, Volume (Units), Historic, 2009-2016
Figure 6: Gynecological Devices Market, North America, Volume (Units), Forecast, 2016-2023
Figure 7: Gynecological Devices Market, North America, Company Share (%) 2016
Figure 8: Gynecological Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 9: Gynecological Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Figure 10: Endometrial Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 11: Female Sterilization Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 12: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 13: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 14: Endometrial Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Figure 15: Female Sterilization Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Figure 16: Uterine Fibroid Ablation Devices Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Figure 17: Uterine Fibroid Embolization Agents Market, Canada, Revenue ($m) USD Constant, Forecast, 2016-2023
Figure 18: Gynecological Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 19: Gynecological Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 20: Endometrial Ablation Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 21: Female Sterilization Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 22: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units), Historic, 2009-2016
Figure 23: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units), Historic, 2009-2016
Figure 24: Endometrial Ablation Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 25: Female Sterilization Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 26: Uterine Fibroid Ablation Devices Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 27: Uterine Fibroid Embolization Agents Market, Canada, Volume (Units), Forecast, 2016-2023
Figure 28: Gynecological Devices Market, Canada, Company Share (%) 2016
Figure 29: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 30: Gynecological Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 31: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 32: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 33: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 34: Endometrial Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 35: Female Sterilization Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 36: Uterine Fibroid Ablation Devices Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 37: Uterine Fibroid Embolization Agents Market, Mexico, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 38: Gynecological Devices Market, Mexico, Volume (Units), Historic, 2009-2016
Figure 39: Gynecological Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Figure 40: Endometrial Ablation Devices Market, Mexico, Volume (Units), Historic, 2009-2016
Figure 41: Female Sterilization Devices Market, Mexico, Volume (Units), Historic, 2009-2016
Figure 42: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Historic, 2009-2016
Figure 43: Endometrial Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Figure 44: Female Sterilization Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Figure 45: Uterine Fibroid Ablation Devices Market, Mexico, Volume (Units), Forecast, 2016-2023
Figure 46: Uterine Fibroid Embolization Agents Market, Mexico, Volume (Units), Forecast, 2016-2023
Figure 47: Gynecological Devices Market, Mexico, Company Share (%) 2016
Figure 48: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 49: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 50: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 51: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 52: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 53: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 54: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 55: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 56: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 57: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 58: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 59: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 60: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 61: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 62: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 63: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016
Figure 64: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 65: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 66: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 67: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023
Figure 68: Gynecological Devices Market, United States, Company Share (%) 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Bayer AG
  • Hologic Inc
  • Utah Medical Products, Inc.
  • CooperSurgical Inc
  • Ethicon Inc
  • Boston Scientific Corp
  • Merit Medical Systems, Inc.
  • Cook Group Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll